Quarterly Results

  • Company Name :
Windlas Biotech Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 543329
  • NSE Symbol:
  • WINDLAS
  • P/E(TTM):
  • 24.80
  • ISIN Demat:
  • INE0H5O01029
  • Div & Yield%:
  • 0.73
  • EPS(TTM):
  • 31.78
  • Book Value(₹):
  • 253.42
  • Market Cap(₹Cr.):
  • 1,660.99
  • Face Value(₹):
  • 5.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 222.40 210.09 202.71
Excise Duty 0.00 0.00 0.00
Net Sales 222.40 210.09 202.71
Other Operating Income 0.00 0.00 0.00
Other Income 3.65 5.24 4.94
Total Income 226.04 215.33 207.65
Total Expenditure 193.84 183.57 177.16
PBIDT 32.20 31.76 30.49
Interest 1.02 1.06 1.33
PBDT 31.19 30.71 29.16
Depreciation 7.60 7.45 8.34
Tax 5.88 5.55 4.61
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -0.09 0.04 -0.06
Reported Profit After Tax 17.80 17.67 16.29
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 17.80 17.67 16.29
EPS (Unit Curr.) 8.48 8.43 7.77
EPS (Adj) (Unit Curr.) 8.48 8.43 7.77
Calculated EPS (Unit Curr.) 8.44 8.43 7.77
Calculated EPS (Adj) (Unit Curr.) 8.44 8.43 7.77
Calculated EPS (Ann.) (Unit Curr.) 33.78 33.71 31.08
Calculated EPS (Adj) (Ann.) (Unit Curr.) 33.78 33.71 31.08
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 10.54 10.48 10.48
Reserve & Surplus 0.00 0.00 0.00
Face Value 5.00 5.00 5.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 14.48 15.12 15.04
PBDTM(%) 14.02 14.62 14.39
PATM(%) 8.00 8.41 8.04